The strain YES with the empty vector was used as control. (PDF 459 KB) Selleck GSK1120212 References
1. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC: Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 2004, 42:485–498.PubMedCrossRef 2. Miceli MH, Diaz JA, Lee SA: Emerging opportunistic yeast infections. Lancet Infect Dis 2011, 11:142–151.PubMedCrossRef 3. Ruhnke M: Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Curr Drug Targets 2006, 7:495–504.PubMedCrossRef 4. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM: Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009, 48:1695–1703.PubMedCrossRef 5. Vandeputte P, Ferrari S, Coste Capmatinib research buy AT: Antifungal resistance and
new strategies to control fungal infections. Int J Microbiol 2012, 2012:713687.PubMed 6. Myoken Y, Kyo T, Sugata T, Murayama SY, Mikami Y: Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility www.selleckchem.com/products/xmu-mp-1.html to voriconazole in patients with hematologic malignancies. Haematologica 2006, 91:287–288.PubMed 7. Chauhan N, Calderone R: Two-component signal transduction proteins as potential drug targets in medically important fungi. Infect Immun 2008, 76:4795–4803.PubMedCrossRef 4-Aminobutyrate aminotransferase 8. Yamada-Okabe T, Mio T, Ono N, Kashima Y, Matsui M, Arisawa M, Yamada-Okabe H: Roles of three histidine kinase genes in hyphal development
and virulence of the pathogenic fungus Candida albicans. J Bacteriol 1999, 181:7243–7247.PubMed 9. Catlett NL, Yoder OC, Turgeon BG: Whole-genome analysis of two-component signal transduction genes in fungal pathogens. Eukaryot Cell 2003, 2:1151–1161.PubMedCrossRef 10. Nemecek JC, Wuthrich M, Klein BS: Global control of dimorphism and virulence in fungi. Science 2006, 312:583–588.PubMedCrossRef 11. Kruppa M, Calderone R: Two-component signal transduction in human fungal pathogens. FEMS Yeast Res 2006, 6:149–159.PubMedCrossRef 12. Desai C, Mavrianos J, Chauhan N: Candida albicans SRR1, a putative two-component response regulator gene, is required for stress adaptation, morphogenesis, and virulence. Eukaryot Cell 2011, 10:1370–1374.PubMedCrossRef 13. Bahn YS: Master and commander in fungal pathogens: the two-component system and the HOG signaling pathway. Eukaryot Cell 2008, 7:2017–2036.PubMedCrossRef 14. Maeda T, Wurgler-Murphy SM, Saito H: A two-component system that regulates an osmosensing MAP kinase cascade in yeast. Nature 1994, 369:242–245.PubMedCrossRef 15. Appleby JL, Parkinson JS, Bourret RB: Signal transduction via the multi-step phosphorelay: not necessarily a road less traveled. Cell 1996, 86:845–848.PubMedCrossRef 16.